AVTR vs VTRS · P/E 13, rev $6.55B vs rev $7.27B
Avantor Inc (AVTR) versus Viatris Inc (VTRS) — a side-by-side from cached financials, not a winner call.
Avantor Inc (AVTR) is a medical instruments & supplies company listed on US.
Viatris Inc (VTRS) is a drug manufacturers - specialty & generic company listed on US.
Latest reported AVTR revenue for 2025-12-31 was $6.55B. Net income was -$530.2M. Revenue was down 3.4% from 2024-12-31 to 2025-12-31. AVTR currently screens at market cap $9.36B and trailing P/E 13.3.
Latest reported VTRS revenue for 2026-06-30 was $7.27B. VTRS currently screens at market cap $10.83B.
AVTR currently screens at market cap $9.36B and trailing P/E 13.3. VTRS currently screens at market cap $10.83B.
Not investment advice. Open the AVTR and VTRS stock pages for the full models.
Not investment advice.